Bleeding risk and prediction model to predict bleeding risk of tissue biopsy for definitive diagnosis in patients with suspected amyloidosis

Introduction Bleeding from the affected organs is a common manifestation of amyloidosis. The risk for perioperative bleeding in patients with amyloidosis remains controversial. In this study, we aimed to compare the bleeding risk of tissue biopsies for a definitive diagnosis between patients with an...

Full description

Saved in:
Bibliographic Details
Main Authors: Watsamon Uraiwan, Pirun Saelue
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Annals of Medicine
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2025.2453088
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587329648197632
author Watsamon Uraiwan
Pirun Saelue
author_facet Watsamon Uraiwan
Pirun Saelue
author_sort Watsamon Uraiwan
collection DOAJ
description Introduction Bleeding from the affected organs is a common manifestation of amyloidosis. The risk for perioperative bleeding in patients with amyloidosis remains controversial. In this study, we aimed to compare the bleeding risk of tissue biopsies for a definitive diagnosis between patients with and without amyloidosis, identify risk factors, and generate a prediction model for bleeding risk in these patients.Methods We enrolled patients aged >15 years who had amyloidosis as part of their differential diagnosis before tissue biopsy. After obtaining histopathological reports, we randomly selected patients with and without amyloidosis at a ratio of 4:1.Results A total of 360 patients were enrolled before tissue biopsy. Bleeding complications were observed in 5.6% and 4.2% of patients with and without amyloidosis, respectively. Amyloidosis was not associated with an increased perioperative bleeding risk (adjusted odds ratio 1.19; 95% confidence interval 0.17–8.41, p = 0.859). Kidney biopsy was a significant risk factor for perioperative bleeding in tissue biopsies. A KiHPL model was generated to predict the bleeding risk. The area under the curve was 0.87, with a good calibration plot for this model.Conclusions Amyloidosis is not associated with an increased risk of bleeding in tissue biopsies. The KiHPL model can predict the bleeding risk of tissue biopsies for a definitive diagnosis in patients with suspected amyloidosis.
format Article
id doaj-art-fa313210568745da8975649f2541da3f
institution Kabale University
issn 0785-3890
1365-2060
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Annals of Medicine
spelling doaj-art-fa313210568745da8975649f2541da3f2025-01-24T14:13:34ZengTaylor & Francis GroupAnnals of Medicine0785-38901365-20602025-12-0157110.1080/07853890.2025.2453088Bleeding risk and prediction model to predict bleeding risk of tissue biopsy for definitive diagnosis in patients with suspected amyloidosisWatsamon Uraiwan0Pirun Saelue1Hematology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hatyai, Songkhla, ThailandHematology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hatyai, Songkhla, ThailandIntroduction Bleeding from the affected organs is a common manifestation of amyloidosis. The risk for perioperative bleeding in patients with amyloidosis remains controversial. In this study, we aimed to compare the bleeding risk of tissue biopsies for a definitive diagnosis between patients with and without amyloidosis, identify risk factors, and generate a prediction model for bleeding risk in these patients.Methods We enrolled patients aged >15 years who had amyloidosis as part of their differential diagnosis before tissue biopsy. After obtaining histopathological reports, we randomly selected patients with and without amyloidosis at a ratio of 4:1.Results A total of 360 patients were enrolled before tissue biopsy. Bleeding complications were observed in 5.6% and 4.2% of patients with and without amyloidosis, respectively. Amyloidosis was not associated with an increased perioperative bleeding risk (adjusted odds ratio 1.19; 95% confidence interval 0.17–8.41, p = 0.859). Kidney biopsy was a significant risk factor for perioperative bleeding in tissue biopsies. A KiHPL model was generated to predict the bleeding risk. The area under the curve was 0.87, with a good calibration plot for this model.Conclusions Amyloidosis is not associated with an increased risk of bleeding in tissue biopsies. The KiHPL model can predict the bleeding risk of tissue biopsies for a definitive diagnosis in patients with suspected amyloidosis.https://www.tandfonline.com/doi/10.1080/07853890.2025.2453088Amyloidosisbleedingrisk factorprediction modeltissue biopsy
spellingShingle Watsamon Uraiwan
Pirun Saelue
Bleeding risk and prediction model to predict bleeding risk of tissue biopsy for definitive diagnosis in patients with suspected amyloidosis
Annals of Medicine
Amyloidosis
bleeding
risk factor
prediction model
tissue biopsy
title Bleeding risk and prediction model to predict bleeding risk of tissue biopsy for definitive diagnosis in patients with suspected amyloidosis
title_full Bleeding risk and prediction model to predict bleeding risk of tissue biopsy for definitive diagnosis in patients with suspected amyloidosis
title_fullStr Bleeding risk and prediction model to predict bleeding risk of tissue biopsy for definitive diagnosis in patients with suspected amyloidosis
title_full_unstemmed Bleeding risk and prediction model to predict bleeding risk of tissue biopsy for definitive diagnosis in patients with suspected amyloidosis
title_short Bleeding risk and prediction model to predict bleeding risk of tissue biopsy for definitive diagnosis in patients with suspected amyloidosis
title_sort bleeding risk and prediction model to predict bleeding risk of tissue biopsy for definitive diagnosis in patients with suspected amyloidosis
topic Amyloidosis
bleeding
risk factor
prediction model
tissue biopsy
url https://www.tandfonline.com/doi/10.1080/07853890.2025.2453088
work_keys_str_mv AT watsamonuraiwan bleedingriskandpredictionmodeltopredictbleedingriskoftissuebiopsyfordefinitivediagnosisinpatientswithsuspectedamyloidosis
AT pirunsaelue bleedingriskandpredictionmodeltopredictbleedingriskoftissuebiopsyfordefinitivediagnosisinpatientswithsuspectedamyloidosis